Viewing Study NCT04591795


Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2025-12-27 @ 1:13 AM
Study NCT ID: NCT04591795
Status: UNKNOWN
Last Update Posted: 2020-10-19
First Post: 2019-05-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II
Sponsor: Mr NARIN KAKATUM
Organization:

Study Overview

Official Title: Efficacy and Safety of Sahastara Remedy Extract Capsules in Treating Primary Osteoarthritis of the Knee Compared With Diclofenac (Clinical Trial Phase II)
Status: UNKNOWN
Status Verified Date: 2020-10
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac (Phase II).
Detailed Description: Sample size 66 volunteers

The patients were divided randomly into 2 treatment groups. The patients in group 1 received the SHT extract 300 mg/day (1 capsule of 100 mg SHT extract three times daily before meals). The patients in group 2 received diclofenac sodium 75 mg/day (1 capsule of 25 mg diclofenac three times daily after meals). In addition, the patients in both groups received 20 mg of omeprazole, 1 capsule before breakfast for protects of Gastrointestinal adverse effects.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: